MILLIMAN DNA - Trademark Details
Status: 661 - Response After Non-Final Action - Entered
Serial Number
90577470
Word Mark
MILLIMAN DNA
Status
661 - Response After Non-Final Action - Entered
Status Date
2022-01-13
Filing Date
2021-03-13
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Law Office Assigned Location Code
M70
Employee Name
NODES, CHRISTOPHER JAM
Statements
Disclaimer with Predetermined Text
"DNA"
Goods and Services
Providing temporary use of an interactive and dynamic web-based software application for developing estimates, intended to help primary and secondary insurance payers better understand the potential utilization and costs associated with cell and gene therapies that are in Phase 2 or later clinical development
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2021-06-14
Primary Code
042
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
HAVERLY MACARTHUR
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2021-03-17 | NEW APPLICATION ENTERED IN TRAM |
| 2021-06-14 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2021-09-09 | ASSIGNED TO EXAMINER |
| 2021-09-17 | NON-FINAL ACTION WRITTEN |
| 2021-09-17 | NON-FINAL ACTION E-MAILED |
| 2021-09-17 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2022-01-13 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2022-01-13 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2022-01-13 | TEAS/EMAIL CORRESPONDENCE ENTERED |
